Efforts to vaccinate “zero-dose” children in the Democratic Republic of the Congo (DRC) will be accelerated thanks to new funding from Gavi, the Vaccine Alliance’s Equity Accelerator Fund (EAF).

Lower-income countries supported by the Alliance are on the road to recovery, with DTP3 vaccine coverage going up by 3 percentage points.

Through a memorandum of understanding (MoU), the three organizations will work together to coordinate and facilitate the exchange of information, experience and knowledge concerning audit and advisory activities.

Twelve countries across different regions in Africa are set to receive 18 million doses of the first-ever malaria vaccine over the next two years.

Gavi’s Board approved new investments in six-in-one (hexavalent) vaccine and approved a long list of potential new vaccines for consideration for inclusion in future Gavi programmes at its Board Meeting, which concluded today